Related Experiment Video
Updated: Apr 19, 2026

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
The screening and morbidity pattern of sickle cell anemia in chhattisgarh
Sumanta Panigrahi1, P K Patra2, P K Khodiar2
1Department of Pediatrics, S.V.P.P.G.I.P. and S.C.B. Medical College and Hospital, Cuttack, Odisha India ; A/6, Sishubhaban Campus. Near High Court, Chandini Chowk, Cuttack, Odisha India.
Insights
This study screened 15,701 individuals for sickle cell anemia in Chhattisgarh, India. The prevalence of sickle cell trait (HbAS) was 10.6%, and sickle cell disease (HbSS) was 0.66%, with variations observed across age groups.
Area of Science:
- Medical Science
- Hematology
- Genetics
Background:
- Sickle cell anemia is a significant public health concern, particularly in certain regions of India.
- Understanding the prevalence and clinical profiles of sickle cell disorders is crucial for targeted interventions.
Purpose of the Study:
- To determine the prevalence of sickle cell anemia in three districts of Chhattisgarh, India.
- To describe the clinical and hematological profiles of patients with sickle cell disease.
Main Methods:
- A cross-sectional study involving screening of 15,701 individuals using solubility tests and Hb electrophoresis.
- High-Performance Liquid Chromatography (HPLC) was used for further characterization of HbSS and inconclusive cases.
- Clinical and hematological parameters were compared between vaso-occlusive crises and steady states.
Main Results:
- The prevalence of sickle cell trait (HbAS) was 10.6% (1,672 individuals) and sickle cell disease (HbSS) was 0.66% (97 individuals).
- Specific genotypes identified included Hb-S and beta-thalassemia minor (SB+), Hb-S and Hb-E (S/HBE), and Hb-S and Hb-D Punjab (S/HBD).
- Homozygous patients exhibited decreased Hb, HCT, MCH, and RBC levels during vaso-occlusive crises compared to steady states (p < 0.001).
Conclusions:
- Sickle cell anemia and trait are prevalent in the studied districts of Chhattisgarh.
- Clinical manifestations, such as vaso-occlusive crises, are associated with significant hematological changes.
- Fetal hemoglobin (HbF) levels above 15-20% may correlate with fewer crises, though high HbF can also indicate severe disease.
Abstract:
Our objective was to find out prevalence of sickle cell anemia among the population of three districts (Kanker, Dantewada and Raigarh) of Chhattisgarh with clinical and hematological profile of sickle cell disease patients. A cross sectional study was done. A total of 15,701 persons collectively from three districts voluntarily attended the mobile camp and were screened for sickle cell anemia. First solubility test were done and were confirmed by Hb electrophoresis. The prevalence of sickle cell trait (HbAS) was 1,672 (10.6 %), sickle cell disease (HbSS) and inconclusive band was 97 (0.66 %). The HbSS and inconclusive band were subjected to HPLC. Among them 12 (0.076 %) cases were double heterozygous for Hb-S and beta thalassemia minor (SB+), 2 (0.012 %) cases were double heterozygous for Hb-S and Hb-E (S/HBE), 1 (0.006 %) case was double heterozygous for Hb-S and Hb-D Punjab (S/HBD) and 22 (0.14 %) cases had Hb-S with Hb-F level more than 20 % (SSF). Maximum number of HbSS cases were 13 (2.29 %) out of 567 children in the age group 0-5 years and HbAS cases were 124 (15.6 %) out of 794 persons in the age group 21-25 years. On comparison between vaso-occlusive and steady state, homozygous patients showed decrease in Hb, HCT, MCH, RBC in vaso-occlusive crises (p < 0.001) than steady state. Also there was one moderate negative correlation in number of blood transfusion (r = 0.46) with fetal hemoglobin (HbF) level. Patients with high HbF can have severe disease. This happens due to uneven distribution of fetal hemoglobin in F-cells with mean HbF remaining constant but in our study, those who had HbF level above 15-20 % were having fewer crises.
Related Concept Videos
Multiple Allele Traits
Chronic Kidney Disease II: Clinical Manifestations
Test for Homogeneity

